Kyowa Kirin

Otemachi Financial City Grand Cube1

Kyowa Kirin Co., Ltd. is a global specialty pharmaceutical company that focuses on bringing innovative drugs and therapies to patients who need them. The company's research and development efforts are primarily concentrated in four therapeutic areas: Oncology, Nephrology, Central Nervous System (CNS), and Immunology & Allergy. Kyowa Kirin strives to create and deliver novel medicines that can make a difference in the lives of patients worldwide.

History

Kyowa Kirin was established through the merger of Kyowa Hakko Kogyo Co., Ltd. and Kirin Pharma Company, Limited. This strategic merger combined Kyowa Hakko's expertise in biotechnology with Kirin Pharma's capabilities in novel drug discovery, creating a leading pharmaceutical company with a strong presence in both the Japanese and global markets.

Research and Development

Kyowa Kirin's R&D strategy is focused on leveraging cutting-edge technologies, including antibody technologies and gene therapy, to develop therapies that address unmet medical needs. The company has a robust pipeline of potential new medicines in various stages of development across its core therapeutic areas.

Oncology

In the field of Oncology, Kyowa Kirin is developing treatments aimed at various types of cancer, employing innovative mechanisms of action to target cancer cells directly while minimizing the impact on healthy cells.

Nephrology

The Nephrology division focuses on addressing kidney diseases, a growing concern worldwide due to the increasing prevalence of diabetes and hypertension. Kyowa Kirin's research in this area aims to provide therapies that can improve the quality of life for patients suffering from chronic kidney conditions.

Central Nervous System

Kyowa Kirin's Central Nervous System (CNS) research is dedicated to tackling some of the most challenging neurological and psychiatric disorders. By exploring novel pathways and targets, the company seeks to bring forward new solutions for diseases with significant unmet needs.

Immunology & Allergy

In Immunology & Allergy, Kyowa Kirin is working on innovative therapies that modulate the immune system to treat autoimmune diseases and allergies. The goal is to develop treatments that can achieve long-term remission or management of these conditions.

Global Presence

Kyowa Kirin has a significant global footprint, with operations and partnerships in over 50 countries. The company's global strategy involves collaborating with other pharmaceutical companies, research institutions, and healthcare professionals to accelerate the development and delivery of its innovative therapies to patients around the world.

Corporate Social Responsibility

Kyowa Kirin is committed to corporate social responsibility (CSR), with initiatives aimed at improving access to healthcare, protecting the environment, and contributing to society. The company's CSR activities reflect its dedication to ethical practices, sustainability, and social well-being.

This article is a stub. You can help WikiMD by registering to expand it. Editing is available only to registered and verified users. WikiMD is a comprehensive, free health & wellness encyclopedia.